Advertisement

Picture Kentro Design Corporate and Web Design for Start Ups 650x80px
Document › Details

Gilead Sciences, Inc.. (2/4/20). "Press Release: Gilead Sciences Announces Fourth Quarter and Full Year 2019 Financial Results". Foster City, CA.

Organisations Organisation Gilead Sciences Inc. (Nasdaq: GILD)
  Group Gilead Sciences (Group)
  Organisation 2 Galapagos N.V. (Euronext + Nasdaq: GLPG)
  Group Galapagos (Group)
Products Product Biktarvy®
  Product 2 Yescarta™
  Index term 2 Kite Pharma–Gilead: investment, 201708–201710 acquisition $11.9b cash tender offer $180/share
Person Person O'Day, Daniel (Gilead 201903 CEO before Roche Pharma CEO + COO + Roche Diagnostics COO joined Roche 1987)
     


   
Record changed: 2020-03-07

Advertisement

Picture [iito] Plain Stupid Simple 650x80px

More documents for Gilead Sciences (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px




» top